The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
Open accessThe DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Abstract
Perhaps the best-studied mucosal adjuvants are the bacterially derived ADP-ribosylating enterotoxins. This adjuvant family includes heat-labile enterotoxin of Escherichia coli (LT), cholera toxin (CT), and mutants or subunits of LT and CT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, a double-mutant labile toxin (dmLT) derived from Escherichia coli is a potent adjuvant that can enhance immune responses to IPV [113,114,115,116].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [114]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Doreau, A., Belot, A., Bastid, J., Riche, B., Trescol-Biemont, M.-C., Ranchin, B., Fabien, N., Cochat, P., Pouteil-Noble, C., Trolliet, P., et al. (2009) · Nature Immunology · doi:10.1038/ni.1741 · Cited by 452
RetractedTrained immunity: A program of innate immune memory in health and– disease
Netea, M. G., Joosten, L. A. B., Latz, E., Mills, K. H. G., Natoli, G., Stunnenberg, H. G., O’Neill, L. A. J., & Xavier, R. J. (2016) · Science · doi:10.1126/science.aaf1098 · Cited by 2,768
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
Mutsch, M., Zhou, W., Rhodes, P., Bopp, M., Chen, R. T., Linder, T., Spyr, C., & Steffen, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030595 · Cited by 916
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development
Levine, M. M., Kaper, J. B., Black, R. E., & Clements, M. L. (1983) · Microbiological Reviews · doi:10.1128/mmbr.47.4.510-550.1983 · Cited by 636
Intestinal ion transport and the pathophysiology of diarrhea
Field, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18326 · Cited by 572
Proinflammatory T helper type 17 cells are effective B-cell helpers
Mitsdoerffer, M., Lee, Y., Jäger, A., Kim, H.-J., Korn, T., Kolls, J. K., Cantor, H., Bettelli, E., & Kuchroo, V. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009234107 · Cited by 534
Interleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 475
Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
Elson, C. O., & Ealding, W. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.6.2736 · Cited by 444
Dickinson, B. L., & Clements, J. D. (1995) · Infection and Immunity · doi:10.1128/iai.63.5.1617-1623.1995 · Cited by 350
Self-citationClements, J. D., & Finkelstein, R. A. (1979) · Infection and Immunity · doi:10.1128/iai.24.3.760-769.1979 · Cited by 330
Self-citationElson, C. O., & Ealding, W. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.6.2892 · Cited by 328
Michetti, P., Kreiss, C., Kotloff, K. L., Porta, N., Blanco, J., Bachmann, D., Herranz, M., Saldinger, P. F., Corthésy–Theulaz, I., Losonsky, G., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70063-6 · Cited by 310
Lewis, D. J. M., Huo, Z., Barnett, S., Kromann, I., Giemza, R., Galiza, E., Woodrow, M., Thierry-Carstensen, B., Andersen, P., Novicki, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006999 · Cited by 305
Clements, J. D., Hartzog, N. M., & Lyon, F. L. (1988) · Vaccine · doi:10.1016/0264-410x(88)90223-x · Cited by 284
Self-citationLycke, N., Tsuji, T., & Holmgren, J. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220915 · Cited by 283
Microbiota-dependent sequelae of acute infection compromise tissue-specific immunity
Fonseca, D. M. D., Hand, T. W., Han, S.-J., Gerner, M. Y., Zaretsky, A. G., Byrd, A. L., Harrison, O. J., Ortiz, A. M., Quinones, M., Trinchieri, G., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.030 · Cited by 281
Tumpey, T. M., Renshaw, M., Clements, J. D., & Katz, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.11.5141-5150.2001 · Cited by 253
Self-citationFreytag, L. C., & Clements, J. D. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.010 · Cited by 252
Self-citationNorton, E. B., Lawson, L. B., Freytag, L. C., & Clements, J. D. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00538-10 · Cited by 221 · cited 8×
“The ribbon diagram of dmLT can be extrapolated from the crystal structure of the partially cleaved LT toxin (1, 2), although there may be as-yet-unresolved changes in three-dimensional (3D) structure due to the amino acid substitutions in the A subunit.”
BackgroundMethodResultSelf-citationLeukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent
Rottman, J. B., Slavin, A. J., Silva, R., Weiner, H. L., Gerard, C. G., & Hancock, W. W. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(2000)30:8<2372::aid-immu2372>3.0.co;2-d · Cited by 204
Kotloff, K. L., Sztein, M. B., Wasserman, S. S., Losonsky, G. A., DiLorenzo, S. C., & Walker, R. I. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.3581-3590.2001 · Cited by 201
Delivery Systems for Intradermal Vaccination
Kim, Y. C., Jarrahian, C., Zehrung, D., Mitragotri, S., & Prausnitz, M. R. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_123 · Cited by 176
Jaffar, Z., Ferrini, M. E., Herritt, L. A., & Roberts, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900237 · Cited by 165
Datta, S. K., Sabet, M., Nguyen, K. P. L., Valdez, P. A., Gonzalez-Navajas, J. M., Islam, S., Mihajlov, I., Fierer, J., Insel, P. A., Webster, N. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002348107 · Cited by 158
Broadly Protective Shigella Vaccine Based on Type III Secretion Apparatus Proteins
Martinez-Becerra, F. J., Kissmann, J. M., Diaz-McNair, J., Choudhari, S. P., Quick, A. M., Mellado‐Sánchez, G., Clements, J. D., Pasetti, M. F., & Picking, W. L. (2011) · Infection and Immunity · doi:10.1128/iai.06174-11 · Cited by 155
Self-citationDefending the mucosa: adjuvant and carrier formulations for mucosal immunity
Lawson, L. B., Norton, E. B., & Clements, J. D. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.03.009 · Cited by 140
Self-citationLundgren, A., Bourgeois, L., Carlin, N., Clements, J., Gustafsson, B., Hartford, M., Holmgren, J., Petzold, M., Walker, R., & Svennerholm, A.-M. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.10.069 · Cited by 135
Self-citationBelyakov, I. M. (2006) · Blood · doi:10.1182/blood-2005-11-4374 · Cited by 135
Holmgren, J. R., Bourgeois, L., Carlin, N., Clements, J. D., Gustafsson, B. I., Lundgren, A., Nygren, E., Tobias, J., Walker, R. I., & Svennerholm, A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.03.027 · Cited by 132
Self-citationBrereton, C. F., Sutton, C. E., Ross, P. J., Iwakura, Y., Pizza, M., Rappuoli, R., Lavelle, E. C., & Mills, K. H. G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003789 · Cited by 113
Lu, Y.-J., Yadav, P., Clements, J. D., Forte, S., Srivastava, A., Thompson, C. M., Seid, R., Look, J., Alderson, M., Tate, A., et al. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00036-10 · Cited by 101
Self-citationNorton, E. B., Lawson, L. B., Mahdi, Z., Freytag, L. C., & Clements, J. D. (2012) · Infection and Immunity · doi:10.1128/iai.00181-12 · Cited by 101
Self-citationIntranasal Delivery of Cholera Toxin Induces Th17-Dominated T-Cell Response to Bystander Antigens
Lee, J.-B., Jang, J.-E., Song, M., & Chang, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005190 · Cited by 94
Pertussis Toxin Enhances Th1 Responses by Stimulation of Dendritic Cells
Hou, W., Wu, Y., Sun, S., Shi, M., Sun, Y., Yang, C., Pei, G., Gu, Y., Zhong, C., & Sun, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1728 · Cited by 93
The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT)
Cheng, E., Cárdenas-Freytag, L., & Clements, J. D. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00168-1 · Cited by 93
Self-citationRyan, E. J., McNeela, E. A., Pizza, M., Rappuoli, R., O'Neill, L. A. J., & Mills, K. H. G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5750 · Cited by 93
Banerjee, S., Medina-Fatimi, A., Nichols, R., Tendler, D., Michetti, M., Simon, J., Kelly, C. P., Monath, T. P., & Michetti, P. (2002) · Gut · doi:10.1136/gut.51.5.634 · Cited by 90
Anosova, N. G., Chabot, S., Shreedhar, V. K., Borawski, J. A., Dickinson, B. L., & Neutra, M. R. (2007) · Mucosal Immunology · doi:10.1038/mi.2007.7 · Cited by 88
Ottsjö, L. S., Flach, C., Clements, J. D., Holmgren, J. R., & Raghavan, S. (2013) · Infection and Immunity · doi:10.1128/iai.01407-12 · Cited by 87
Self-citationGerber, S., Lane, C., Brown, D. M., Lord, E. M., DiLorenzo, M., Clements, J. D., Rybicki, E. P., Williamson, A., & Rose, R. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4752-4760.2001 · Cited by 85
Self-citationvan Ginkel, F. W., Jackson, R. J., Yoshino, N., Hagiwara, Y., Metzger, D., Connell, T. D., Vu, H. L., Martin, M., Fujihashi, K., & McGhee, J. R. (2005) · Infection and Immunity · doi:10.1128/iai.73.10.6892-6902.2005 · Cited by 84
Larena, M., Holmgren, J. R., Lebens, M., Terrinoni, M., & Lundgren, A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401633 · Cited by 83
Silk Fibroin Microneedles for Transdermal Vaccine Delivery
Stinson, J. A., Raja, W. K., Lee, S., Kim, H. B., Diwan, I. M., Tutunjian, S., Panilaitis, B., Omenetto, F. G., Tzipori, S. R., & Kaplan, D. L. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00515 · Cited by 82
Lobet, Y., Cluff, C. W., & Cieplak, W. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.2870-2879.1991 · Cited by 80
Bagley, K., Abdelwahab, S. F., Tuskan, R. G., FOUTS, T. R., & Lewis, G. K. (2002) · Infection and Immunity · doi:10.1128/iai.70.10.5533-5539.2002 · Cited by 79
Norton, E. B., Bauer, D. L., Weldon, W. C., Oberste, M. S., Lawson, L. B., & Clements, J. D. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.02.069 · Cited by 76
Self-citationSummerton, N. A., Welch, R. W., Bondoc, L., Yang, H.-H., Pleune, B., Ramachandran, N., Harris, A. M., Bland, D., Jackson, W. J., Park, S., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.10.147 · Cited by 75
Self-citationHertz, A. L., Bender, A. T., Smith, K. C., Gilchrist, M., Amieux, P. S., Aderem, A., & Beavo, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911684106 · Cited by 73
Fahlén‐Yrlid, L., Gustafsson, T., Westlund, J., Holmberg, A. H., Strömbeck, A., Blomquist, M., MacPherson, G. G., Holmgren, J. R., & Yrlid, U. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803992 · Cited by 72
Kaminski, R. W., Wu, M., Turbyfill, K. R., Clarkson, K. A., Tai, B., Bourgeois, A. L., Verg, L. L. V. D., Walker, R. I., & Oaks, E. V. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00683-13 · Cited by 71
Leach, S., Clements, J. D., Kaim, J., & Lundgren, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051718 · Cited by 71
Self-citationTamura, S.-I., Asanuma, H., Tomita, N., Komase, K., Kawahara, K., Danbara, H., Hattori, N., Watanabe, K., Suzuki, Y., Nagamine, T., et al. (1994) · Vaccine · doi:10.1016/0264-410x(94)90177-5 · Cited by 69
Singh, J. K., Bhatia, R., Gandhi, J. C., Kaswekar, A. P., Khare, S., Patel, S. B., Oza, V. B., Jain, D. C., & Sokhey, J. (1998) · Europe PMC (PubMed Central) · Cited by 67
Smiley, K. L., McNeal, M., Basu, M., Choi, A. H.-C., Clements, J. D., & Ward, R. L. (2007) · Journal of Virology · doi:10.1128/jvi.01877-06 · Cited by 65
Self-citationQuan, F. S., Yoo, D.-G., Song, J.-M., Clements, J. D., Compans, R. W., & Kang, S.-M. (2009) · Journal of Virology · doi:10.1128/jvi.02035-08 · Cited by 64
Self-citationNorton, E. B., Clements, J. D., Voss, T. G., & Cárdenas-Freytag, L. (2010) · Journal of Virology · doi:10.1128/jvi.01805-09 · Cited by 62
Self-citationEl-Kamary, S. S., Cohen, M. B., Bourgeois, A. L., Van De Verg, L., Bauers, N., Reymann, M., Pasetti, M. F., & Chen, W. H. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00464-13 · Cited by 62
Ruan, X., Sack, D. A., & Zhang, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121623 · Cited by 61
Heine, S. J., Diaz-McNair, J., Andar, A. U., Drachenberg, C. B., Verg, L. V. D., Walker, R. I., Picking, W. L., & Pasetti, M. F. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302743 · Cited by 61
Development of a Bacillus subtilis -Based Rotavirus Vaccine
Lee, S., Belitsky, B. R., Brinker, J. P., Kerstein, K. O., Brown, D. W., Clements, J. D., Keusch, G. T., Tzipori, S., Sonenshein, A. L., & Herrmann, J. E. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00135-10 · Cited by 56
Self-citationNovotny, L. A., Clements, J. D., & Bakaletz, L. O. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.6 · Cited by 55
Self-citationFrederick, D. R., Goggins, J. A., Sabbagh, L. M., Freytag, L. C., Clements, J. D., & McLachlan, J. B. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.70 · Cited by 55
Self-citationBioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen
Hayden, C. A., Streatfield, S. J., Lamphear, B. J., Fake, G. M., Keener, T. K., Walker, J. H., Clements, J. D., Turner, D. D., Tizard, I. R., & Howard, J. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.02.072 · Cited by 52
Self-citationJaffar, Z. H., Ferrini, M. E., Girtsman, T., & Roberts, K. (2009) · European Journal of Immunology · doi:10.1002/eji.200939498 · Cited by 52
Glynn, A. R., Roy, C. J., Powell, B. S., Adamovicz, J. J., Freytag, L. C., & Clements, J. D. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.5256-5261.2005 · Cited by 52
Self-citationWhite, J. A., Blum, J. S., Hosken, N. A., Marshak, J. O., Duncan, L., Zhu, C., Norton, E. B., Clements, J. D., Koelle, D. M., Chen, D., et al. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.32253 · Cited by 51
Self-citationEffect of adjuvants and route of immunizations on the immune response to recombinant plague antigens
Uddowla, S., Freytag, L. C., & Clements, J. D. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.09.030 · Cited by 49
Self-citationLu, X., Clements, J. D., & Katz, J. M. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00452-2 · Cited by 47
Self-citationNovotny, L. A., Clements, J. D., & Bakaletz, L. O. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.10.033 · Cited by 46
Self-citationStructure of partially‐activated E. coli heat‐labile enterotoxin (LT) at 2.6 Å resolution
Merritt, E. A., Pronk, S. E., Sixma, T. K., Kalk, K. H., van Zanten, B. A. M., & Hol, W. G. J. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80635-7 · Cited by 43
Norton, E. B., Branco, L. M., & Clements, J. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136302 · Cited by 39
Self-citationAlam, M. M., Bufano, M. K., Xu, P., Kalsy, A., Yu, Y., Freeman, Y. W., Sultana, T., Rashu, M. R., Desai, I., Eckhoff, G., et al. (2014) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002683 · Cited by 37
Self-citationAylward, B., Kane, M., McNAIR-SCOTT, R., & HU, D. H. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.2.446 · Cited by 36
Luo, Q., Vickers, T. J., & Fleckenstein, J. M. (2016) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00248-16 · Cited by 36
Coleman, B. L., McGeer, A., Halperin, S. A., Langley, J. M., Shamout, Y., Taddio, A., Shah, V. S., & McNeil, S. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.08.006 · Cited by 34
Negri, D. R. M., Pinto, D., Vendetti, S., Patrizio, M., Sanchez, M., Riccomi, A., Ruggiero, P., Giudice, G. D., & Magistris, M. T. D. (2009) · Infection and Immunity · doi:10.1128/iai.01559-08 · Cited by 32
Ottsjö, L. S., Jeverstam, F., Yrlid, L., Wenzel, A. U., Walduck, A. K., & Raghavan, S. (2016) · Immunology · doi:10.1111/imm.12676 · Cited by 30
McNeal, M., Stone, S. C., Basu, M., Clements, J. D., Choi, A. H.-C., & Ward, R. L. (2007) · Viral Immunology · doi:10.1089/vim.2007.0055 · Cited by 28
Self-citationNovotny, L. A., Clements, J. D., Goodman, S. D., & Bakaletz, L. O. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00563-16 · Cited by 28
Self-citationShigella Outer Membrane Protein PSSP-1 Is Broadly Protective against Shigella Infection
Kim, J., Rho, S., Kim, S. H., Kim, H. J., Song, H. J., Kim, E. J., Kim, R. Y., Kim, E. H., Sinha, A., Dey, A., et al. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00661-14 · Cited by 26
Lee, S., Picking, W. L., & Tzipori, S. R. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.07.013 · Cited by 22
Cyclic Nucleotides and Phosphodiesterases in Monocytic Differentiation
Hertz, A. L., & Beavo, J. A. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17969-3_16 · Cited by 20
Therapeutic Transcutaneous Immunization with a Band-Aid Vaccine Resolves Experimental Otitis Media
Novotny, L. A., Clements, J. D., & Bakaletz, L. O. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00090-15 · Cited by 19
Self-citationToprani, V. M., Sahni, N., Hickey, J. M., Robertson, G. A., Middaugh, C. R., Joshi, S. B., & Volkin, D. B. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.03.101 · Cited by 19
Lalsiamthara, J., Kamble, N. M., & Lee, J. H. (2016) · Veterinary Research · doi:10.1186/s13567-016-0348-7 · Cited by 17
Maldarelli, G. A., & Matz, H. C. (2016) · Journal of Vaccines & Vaccination · doi:10.4172/2157-7560.1000321 · Cited by 17
Evaluation of combinatorial vaccines against anthrax and plague in a murine model
DuBois, A. B., Freytag, L. C., & Clements, J. D. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.048 · Cited by 15
Self-citationWhite, J. A., Haghighi, C., Brunner, J., Estrada, M., Lal, M., & Chen, D. (2017) · Journal of Immunological Methods · doi:10.1016/j.jim.2017.09.003 · Cited by 15
Nguyen, H.-N. P., Steede, N. K., Robinson, J. E., & Landry, S. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.082 · Cited by 14
Lalsiamthara, J., & Lee, J. H. (2017) · Vaccine · doi:10.1016/j.vaccine.2016.12.042 · Cited by 14
Albert, M. J., Haridas, S., Ebenezer, M., Raghupathy, R., & Khan, I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142090 · Cited by 13
Tennant, S. M., Steele, A. D., & Pasetti, M. F. (2016) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00082-16 · Cited by 7
Research works printed but not linked: 4
- Oplinger ML, Baqar S, Trofa AF, Clements JD, Gibbs P, Pazzaglia G, Bourgeois AL, Scott DA. 1997. Safety and immunogenicity in volunteers of a new candidate oral mucosal adjuvant, LT(R192G), p 193. Abstr 37th Intersci Conf Antimicrob Agents Chemother. American Society for Microbiology, Washington, DC.
- 10.1128/mr.47.4.510-550.1983 · doi:10.1128/mr.47.4.510-550.1983 · Paper page
- Tribble DR, Baqar S, Thompson SA. 2008. Development of a human vaccine, p 429–444. In Nachamkin I, Szymanski CM, Blaser MJ (ed), Campylobacter, 3rd ed. ASM Press, Washington, DC.
- 10.1002/1521-4141(2000)30:8<2394::aid-immu2394>3.0.co;2-y · DOI · Paper page
Cited by
Mucosal vaccines — fortifying the frontiers
Lavelle, E. C., & Ward, R. W. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00583-2 · Cited by 752
Recombinant protein vaccines, a proven approach against coronavirus pandemics
Pollet, J., Chen, W.-H., & Strych, U. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.001 · Cited by 277
Pokharel, P., Dhakal, S., & Dozois, C. M. (2023) · Microorganisms · doi:10.3390/microorganisms11020344 · Cited by 207
New-age vaccine adjuvants, their development, and future perspective
Verma, S. K., Mahajan, P., Singh, N. K., Gupta, A., Aggarwal, R., Rappuoli, R., & Johri, A. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1043109 · Cited by 190
Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines
Gong, X., Gao, Y., Shu, J., Zhang, C., & Zhao, K. (2022) · Vaccines · doi:10.3390/vaccines10111906 · Cited by 155
Metadata
- Authors
- Clements, J. D., & Norton, E. B.
- Affiliations
- Tulane University (US)
- Corresponding author
- Norton, Elizabeth B.
- Venue
- mSphere
- Publisher
- American Society for Microbiology
- Published
- 2018-08-29
- Volume
- 3
- Issue
- 4
- ISSN
- 2379-5042 (ISSN-L)
- PMC
- PMC6060342
- OpenAlex
- W2883931539
- Cited by
- 177
- References
- 92
- Citations by year
- 2026: 16 · 2025: 14 · 2024: 14 · 2023: 40 · 2022: 21 · 2021: 29 · 2020: 27 · 2019: 15
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mSphere (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI114697, NIH2012146)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- cholera toxin B subunit, mucosal immunization, IgA antibodies, Th1/Th2/Th17 responses, cytotoxic T lymphocytes, adjuvant mechanisms, preclinical and clinical trials, vaccine formulation
- MeSH terms
- Adjuvants, Immunologic, Bacterial Toxins, Enterotoxins, Vaccines, Protein Subunits, Escherichia coli Proteins, Mutant Proteins, Administration, Mucosal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

